Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic comparison of thienopyridine loading strategies in patients undergoing elective coronary stenting
DRKS00006102Phase 3Completed
- Sponsor
- Universitäts-Herzzentrum Freiburg-Bad Krozingen
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of prasugrel and clopidogrel in Chronic Coronary Syndrome (CCS) (3 arms), sponsored by Universitäts-Herzzentrum Freiburg-Bad Krozingen. Primary endpoint: Pharmacodynamic response to thienopyridine loading strategies. Started May 2014; status: completed.
02
Drugs
prasugrelclopidogrel
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on DRKS00006102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00006102.